{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:37Z","timestamp":1789690657306,"version":"4.0.1"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.592199","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:32:21Z","timestamp":1603672341000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others\u2013A Perspective of German Addiction Medicine Experts"],"prefix":"10.3389","volume":"11","author":[{"given":"Udo","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Specka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Hermle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Hilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hillemacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Luckhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"L\u00fcdecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Welf","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Stuppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard A.","family":"Wiesbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wodarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heath","family":"McAnally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1124\/pr.115.010967","article-title":"Mechanisms of action and persistent neuroplasticity by drugs of abuse","volume":"67","author":"Korpi","year":"2015","journal-title":"Pharmacol Rev."},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.4135\/9781071800485","volume-title":"Counseling and Professional Identity in the 21st Century. Substance use Disorders and Addictions","author":"Morgen","year":"2017"},{"key":"B3","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"B4","volume-title":"Taschenf\u00fchrer zur ICD-10-Klassifikation psychischer St\u00f6rungen.","author":"Dilling","year":"2006"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Independent Scientific Committee on Drugs. Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000317249","article-title":"Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population","volume":"16","author":"van Amsterdam","year":"2010","journal-title":"Eur Addict Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e000774","DOI":"10.1136\/bmjopen-2011-000774","article-title":"Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland","volume":"2","author":"Taylor","year":"2012","journal-title":"BMJ Open."},{"key":"B8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1360-0443.2011.03675.x","article-title":"A damage\/benefit evaluation of addictive product use","volume":"107","author":"Bourgain","year":"2012","journal-title":"Addiction."},{"key":"B9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/0269881119841569","article-title":"The Australian drug harms ranking study","volume":"33","author":"Bonomo","year":"2019","journal-title":"J Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1177\/0269881115581980","article-title":"European rating of drug harms","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J Psychopharmacol."},{"key":"B11","unstructured":"Die Drogenbeauftragte der Bundesregierung2018"},{"key":"B12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3238\/arztebl.2019.0577","article-title":"The use of alcohol, tobacco, illegal drugs and medicines. An estimate of consumption and substance-related disorders in Germany","volume":"116","author":"Atzendorf","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3238\/arztebl.2019.0585","article-title":"Trends in substance use and related disorders\u2014analysis of the epidemiological survey of substance abuse 1995 to 2018","volume":"116","author":"Seitz","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1055\/s-0043-102059","article-title":"New psychoactive substances (NPS) - a challenge for the addiction treatment services","volume":"50","author":"Scherbaum","year":"2017","journal-title":"Pharmacopsychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1080\/14656566.2017.1409722","article-title":"Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus","volume":"18","author":"Dematteis","year":"2017","journal-title":"Expert Opin Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008-2017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiatry."},{"key":"B18","unstructured":"LuxembourgPublications Office of the European Union2018 Medical use of Cannabis and Cannabinoids: Questions and Answers for Policymaking.2018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1055\/s-0031-1273411","article-title":"Assessment of the addictive risk of propofol","volume":"79","author":"Bonnet","year":"2011","journal-title":"Fortschr Neurol Psychiatry."},{"key":"B20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00228-009-0769-6","article-title":"Drug dependence associated with triptans and ergot derivatives: a case\/non-case study","volume":"66","author":"Beau-Salinas","year":"2010","journal-title":"Eur J Clin Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1002\/jcph.164","article-title":"Abuse liability of flupirtine revisited: implications of spontaneous reports of adverse drug reactions","volume":"53","author":"Gahr","year":"2013","journal-title":"J Clin Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"Eur Neuropsychopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.addbeh.2018.11.009","article-title":"Screening for physical and behavioral dependence on non-opioid analgesics in a German elderly hospital population","volume":"90","author":"Bonnet","year":"2019","journal-title":"Addict Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0034-1371868","article-title":"Ibuprofen dependence: a case report","volume":"47","author":"Etcheverrigaray","year":"2014","journal-title":"Pharmacopsychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.addbeh.2017.02.008","article-title":"Identification of non-steroidal anti-inflammatory drug use disorder: a case report","volume":"70","author":"Godersky","year":"2017","journal-title":"Addict Behav."},{"key":"B27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.amjms.2016.08.028","article-title":"Overuse and misperceptions of nonsteroidal anti-inflammatory drugs in the United States","volume":"352","author":"Cryer","year":"2016","journal-title":"Am J Med Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.17219\/acem\/58887","article-title":"Correlates of abusing and misusing over-the-counter pain relievers among adult population of Wroc\u0142aw (Poland)","volume":"25","author":"W\u00f3jta-Kempa","year":"2016","journal-title":"Adv Clin Exp Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00115-008-2412-7","article-title":"Use of an outpatient treatment center for cannabis abuse","volume":"79","author":"H\u00f6lscher","year":"2008","journal-title":"Nervenarzt."},{"key":"B30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0041-106313","article-title":"Frequent non-medical cannabis use: health sequelae and effectiveness of detoxification treatment","volume":"141","author":"Bonnet","year":"2016","journal-title":"Dtsch Med Wochenschr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1024\/0939-5911\/a000405","article-title":"Konsumfolgen und Behandlungsbedarf von Cannabis-Intensivkonsumenten\/innen im ambulanten setting","volume":"62","author":"Schneider","year":"2016","journal-title":"Sucht."},{"key":"B32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00414-018-1891-8","article-title":"Phenotypic effects of chronic and acute use of methiopropamine in a mouse model","volume":"133","author":"Foti","year":"2019","journal-title":"Int J Legal Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bcp.14183","article-title":"How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances","volume":"86","author":"Corkery","year":"2020","journal-title":"Br J Clin Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"116715","DOI":"10.1016\/j.jns.2020.116715","article-title":"A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses","volume":"411","author":"Chi","year":"2020","journal-title":"J Neurol Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e599","DOI":"10.1097\/PR9.0000000000000599","article-title":"The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents","volume":"2","author":"H\u00e4user","year":"2017","journal-title":"Pain Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3238\/arztebl.2019.0137","article-title":"Estimation of the number of people with opioid addiction in Germany","volume":"116","author":"Kraus","year":"2019","journal-title":"Dtsch Arztebl Int."},{"key":"B37","first-page":"e0221153","article-title":"Opioid prescription patterns in germany and the global opioid epidemic: systematic review of available evidence","volume-title":"PLoS ONE","author":"Rosner","year":"2019"},{"key":"B38","first-page":"45","article-title":"Prescription opioid prescribing in Western Europe and the United States","volume":"103","author":"Meyer","year":"2020","journal-title":"R I Med J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.yrtph.2015.09.014","article-title":"Ranking the harm of non-medically used prescription opioids in the UK","volume":"73","author":"van Amsterdam","year":"2015","journal-title":"Regul Toxicol Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.yhbeh.2009.09.012","article-title":"Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones","volume":"58","author":"Bodnar","year":"2010","journal-title":"Horm Behav."},{"key":"B41","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fpsyt.2017.00256","article-title":"Gender differences and psychopathological features associated with addictive behaviors in adolescents","volume":"8","author":"Di Nicola","year":"2017","journal-title":"Front Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10479-007-0183-3","article-title":"Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing","volume":"154","author":"Phillips","year":"2007","journal-title":"Ann Operat Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.drugpo.2011.04.004","article-title":"Questioning the method and utility of ranking drug harms in drug policy","volume":"22","author":"Rolles","year":"2011","journal-title":"Int J Drug Policy."},{"key":"B44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/pds.3636","article-title":"Balancing benefit and risk of medicines: a systematic review and classification of available methodologies","volume":"23","author":"Mt-Isa","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B45","article-title":"Substance related exogenous psychosis: a post-modern syndrome","volume-title":"CNS Spectr.","author":"Martinotti","year":"2020"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.592199\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:32:29Z","timestamp":1603672349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2020.592199\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":45,"alternative-id":["10.3389\/fpsyt.2020.592199"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.592199","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"article-number":"592199"}}